Concepedia

Author

Lan Mu

Chinese Academy of Medical Sciences & Peking Union Medical CollegeORCID

Also Known As

L Mu, Lan Mu, Mu, Lan

46

Publications

565

Citations

12

H-Index

9

Concepts

All Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical CollegeSecond Xiangya Hospital of Central South UniversityIcahn School of Medicine at Mount SinaiJiangsu Hengrui Medicine (China)Central South University
LM

About

Lan Mu is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in radiation oncology, immunology, and tumor immunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

12

2

Immunology

1

1

12

3

Pathology

1

1

12

4

Cancer Therapeutics

1

1

12

5

Immunotherapy

1

1

12

Lan Mu

×

9

Publications

310

Citations

9

H-Index

YearCitations

Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma

Bo Zhang, Ling Qi, Xi Wang,

Cancer Communications

2020

135

Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma

Lan Mu, Ke Ding, Ranran Tu,

Journal of Translational Medicine

2021

42

<scp>SHR‐1316</scp>, an <scp>anti‐PD‐L1</scp> antibody, plus chemotherapy as the first‐line treatment for advanced esophageal squamous cell carcinoma: A multicentre, phase <scp>2</scp> study

Lan Mu, Yan Song, Kuaile Zhao,

Thoracic Cancer

2021

32

Human papillomavirus infection increases the risk of breast carcinoma: a large-scale systemic review and meta-analysis of case-control studies

Chutong Ren, Kai Zeng, Chujun Wu,

Gland Surgery

2019

27

Clinicopathological characteristics and prognosis of metaplastic carcinoma of the breast

Meng Xiao, Zhengjun Yang, Xiaochuan Tang,

Oncology Letters

2017

19

Trends in lobectomy/amygdalohippocampectomy over time and the impact of hospital surgical volume on hospitalization outcomes: A population‐based study

Churl‐Su Kwon, Leah J. Blank, Lan Mu,

Epilepsia

2020

17

Determining an infectious or autoimmune etiology in encephalitis

Hai Ethan Hoang, Jessica Robinson‐Papp, Lan Mu,

Annals of Clinical and Translational Neurology

2022

16

Phase 2 study of camrelizumab (anti-PD-1 antibody) combined with apatinib and chemotherapy for the first-line treatment of advanced esophageal squamous cell carcinoma.

Bo Zhang, Ling Qi, Xi Wang,

Journal of Clinical Oncology

2019

12

Transcriptional Expressions of ALDH1A1/B1 as Independent Indicators for the Survival of Thyroid Cancer Patients

Ying Cui, Yao Liu, Lan Mu,

Frontiers in Oncology

2022

10

Page 1